Everlight Radiology and The HLH Imaging Group announce strategic partnership to support NHS cardiac CT, cardiac MRI and prostate MRI services
Everlight Radiology and The HLH Imaging Group (HLH), both leading providers in teleradiology and subspecialist reporting services, today announce a strategic partnership to deliver highly specialist cardiac CT/MRI and advanced prostate MRI reporting services to NHS trusts across the UK.
This partnership brings together Everlight Radiology’s established operational scale, resilient service delivery model and experience supporting complex NHS imaging pathways with HLH’s nationally recognised subspecialist expertise in cardiac and prostate MRI reporting.
Together, Everlight and HLH will provide NHS organisations with a robust, clinically led solution to support rising demand for advanced non-invasive imaging while maintaining the highest standards of quality, governance and turnaround times.
A clinically-led partnership designed for NHS capacity and resilience
Demand for cardiac CT coronary angiography (CTCA), cardiac MRI and prostate MRI continues to grow as NHS trusts expand non-invasive diagnostics across cardiology and urology pathways, including coronary artery disease, cardiomyopathy and prostate cancer diagnostics. The Everlight–HLH partnership has been designed specifically to support these pressures, offering a scalable and dependable reporting service aligned with NHS England and Royal College of Radiologists (RCR) guidance, as well as BSCI and BSCMR standards for cardiac imaging.
Through this partnership, Everlight Radiology will lead service delivery to NHS trusts, providing a single, integrated operational interface. HLH will deliver subspecialist reporting across cardiac CT, cardiac MRI and prostate MRI, undertaken exclusively by highly qualified NHS consultant radiologists with substantial subspecialty expertise. All reporting radiologists demonstrate active, high-volume caseloads in their respective domains and report using structured, standardised templates to ensure consistency, clarity and clinical relevance.
Everlight Radiology will underpin the service through its secure technology platforms, resilient operational infrastructure and proven experience integrating seamlessly with NHS PACS and RIS environments. This enables rapid mobilisation, reliable turnaround times and service continuity, even during periods of peak demand.
Daniel Sourial, chief executive officer UKI of Everlight Radiology, said: “Everlight Radiology’s mission is to ensure all patients have access to best-in-class radiologists and their expertise. Our collaboration with HLH ensures patients across the UK have timely access to the highest quality cardiac and prostate reporting. Together, we’re strengthening NHS capacity and resilience while keeping quality and patient care at the heart of everything we do.”
Professor Sam Hare, chief executive officer of The HLH Imaging Group, said: “The partnership between Everlight and HLH represents a paradigm shift in the delivery of teleradiology. Harnessing the unique but complimentary strengths of both organisations means patients and NHS sites will benefit from HLH’s agile level of expertise across niche subspecialist areas of radiology powered by the scale and operational infrastructure of Everlight. We welcome Everlight’s innovative and forward-thinking approach, which will help set a new benchmark for how high-quality teleradiology services are delivered in the UK and beyond.”
Quality, governance and clinical confidence
Quality and governance sit at the heart of the partnership across both cardiac and prostate MRI services. HLH’s subspecialist reporting pathways operate within a mature governance framework, including stringent credentialing, ongoing professional development, discrepancy review and continuous quality assurance. Reports are structured in line with national standards to support downstream clinical decision-making, MDT discussion and patient management across cardiology and urology services.
By combining Everlight’s operational resilience and scale with HLH’s subspecialist clinical leadership, the partnership offers NHS trusts confidence that advanced imaging studies are reported accurately, consistently and in a timely manner, without compromising patient safety or clinical standards.
This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.
